ARAV
$5.02
Aravive
($.26)
(4.92%)
ARAV
Earnings Whisper ®
N/A
3rd Quarter September 2020
Consensus:  ($0.42)
Revenue:  $0.00 Mil
Thursday
Nov 5
4:00 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when ARAV reports earnings?
Beat
Meet
Miss

Where is ARAV's stock price going from here?
Up
Flat
Down
Stock chart of ARAV
Analysts
Summary of analysts' recommendations for ARAV
Score
Grade
Pivots
Resistance
$6.01
$5.75
$5.52

$5.26

Support
$5.03
$4.77
$4.54
Tweet
Growth
Description
Aravive Inc. is a biotechnology company. It develops therapeutic proteins for the treatment of metabolic diseases and endocrine disorders. Aravive Inc. is based in TX, United States.